Eligibility of rheumatoid arthritis patients for anti-TNF-alpha therapy according to the 2005 recommendations of the French and British Societies for Rheumatology.

Fautrel, B; Flipo, R M; Saraux, A

Fautrel, B; Flipo, R M; Saraux, A.

Affiliation

Fautrel B; Service de Rhumatologie, Groupe Hospitalier Pitié-Salpêtrière, 83, boulevard de l'Hôpital, 75651 Paris Cedex 13, France. bruno.fautrel@psl.ap-hop-paris.fr

Rheumatology (Oxford) ; 47(11): 1698-703, 2008 Nov.

Article in En | MEDLINE | ID: mdl-18794185

Subject(s)

Arthritis, Rheumatoid/drug therapy; Eligibility Determination; Immunosuppressive Agents/therapeutic use; Rheumatology; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Aged; Antirheumatic Agents/therapeutic use; Female; France; Health Planning Guidelines; Humans; Male; Methotrexate/therapeutic use; Middle Aged; Societies, Medical; Treatment Failure; United Kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatology / Tumor Necrosis Factor-alpha / Eligibility Determination / Immunosuppressive Agents Type of study: Guideline / Prognostic_studies / Qualitative_research Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2008 Document type: Article Affiliation country: France Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google